The association of prior paracetamol intake with outcome of very old intensive care patients with COVID-19: results from an international prospective multicentre trial
Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences
Critical Care
IMPACT
paracetamol
Critical Illness
610
610 Medicine & health
frailty
ANALGESIA
03 medical and health sciences
0302 clinical medicine
Analgesics; COVID-19; Frailty; ICU; Paracetamol
616
Medicine and Health Sciences
Humans
Prospective Studies
Analgesics, COVID-19, Frailty, ICU, Paracetamol
ELDERLY-PATIENTS
FRAILTY
Pandemics
Acetaminophen
Analgesics
Frailty
COVID-19 ; Medical and Health Sciences ; Paracetamol ; Research ; ICU ; Frailty ; Analgesics
Research
RC952-954.6
COVID-19
3. Good health
Paracetamol
Geriatrics
ICU
SURVIVAL
analgesics
DOI:
10.1186/s12877-022-03709-w
Publication Date:
2022-12-27T23:02:26Z
AUTHORS (178)
ABSTRACT
Abstract Background In the early COVID-19 pandemic concerns about correct choice of analgesics in patients with were raised. Little data was available on potential usefulness or harmfulness prescription free analgesics, such as paracetamol. This international multicentre study addresses that lack evidence regarding harm paracetamol intake prior to ICU admission a setting disease within large, prospectively enrolled cohort critically ill and frail intensive care unit (ICU) patients. Methods prospective observation (The COVIP study) recruited ≥ 70 years admitted COVID-19. Data Sequential Organ Failure Assessment (SOFA) score, 10 days before admission, therapy, limitations survival during stay, at 30 days, 3 months. Paracetamol analysed for associations ICU-, 30-day- 3-month-mortality using Kaplan Meier analysis. Furthermore, sensitivity analyses used stratify 30-day-mortality subgroups patient-specific characteristics logistic regression. Results 44% 2,646 recorded took There no difference age between without intake. Patients taking suffered from more co-morbidities, namely diabetes mellitus (43% versus 34%, p < 0.001), arterial hypertension (70% 65%, = 0.006) had higher score Clinical Frailty Scale (CFS; IQR 2–5 2–4, 0.001). under treatment less often subjected intubation vasopressor use, compared (65 71%, 0.001; 63 69%, 0.007). not associated 3-month-mortality, remaining true after multivariate adjusted Conclusion short-term 3-month mortality old, suffering Trial registration. registered ClinicalTrials.gov identifier “NCT04321265” March 25, 2020.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....